ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 597,52
-0,23%
Dow Jones
42 063,36
0,09%
DAX
18 720,01
-1,47%
Brent Oil
74,135
0,00%
Bitcoin
63 034,01
-0,27%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Quanterix Corporation (QTRX)

  7. Quanterix Corporation (QTRX) Actualités

QTRX

Quanterix (QTRX)

Quanterix Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:QTRX
DateHeureSourceTitreSymboleSociété
17/09/202422h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTRXQuanterix Corporation
29/08/202422h00Business WireQuanterix to Participate at the Morgan Stanley 22nd Annual Global Healthcare ConferenceNASDAQ:QTRXQuanterix Corporation
21/08/202422h29Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:QTRXQuanterix Corporation
21/08/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QTRXQuanterix Corporation
19/08/202422h32Business WireJeffrey Elliott Appointed to Quanterix’s Board of DirectorsNASDAQ:QTRXQuanterix Corporation
16/08/202412h03IH Market NewsDeutsche Bank Faces Shareholder Backlash, Bank of America Sponsors 2026 World Cup, Quanterix CEO Buys More SharesNASDAQ:QTRXQuanterix Corporation
08/08/202422h59Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:QTRXQuanterix Corporation
08/08/202422h00Business WireQuanterix Releases Financial Results for the Second Quarter of 2024NASDAQ:QTRXQuanterix Corporation
06/08/202422h00Business WireQuanterix Presenting at Canaccord Genuity 44th Annual Growth ConferenceNASDAQ:QTRXQuanterix Corporation
31/07/202422h00Business WireQuanterix To Report Second Quarter 2024 Financial ResultsNASDAQ:QTRXQuanterix Corporation
29/07/202414h00Business WireQuanterix Presents Data Demonstrating Successful Multi-Marker Approach for Alzheimer’s Disease Detection that is More Effective than Standalone Plasma p-Tau 217NASDAQ:QTRXQuanterix Corporation
17/06/202422h00Business WireQuanterix to Participate at the Scotiabank Healthcare 1x1 DayNASDAQ:QTRXQuanterix Corporation
12/06/202423h08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:QTRXQuanterix Corporation
05/06/202422h00Business WireQuanterix to Present at 45th Annual Goldman Sachs Global Healthcare ConferenceNASDAQ:QTRXQuanterix Corporation
31/05/202422h01Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:QTRXQuanterix Corporation
22/05/202422h00Business WireQuanterix to Present at Leerink Partners Healthcare Crossroads Conference 2024NASDAQ:QTRXQuanterix Corporation
07/05/202422h00Business WireQuanterix Releases Financial Results for the First Quarter of 2024NASDAQ:QTRXQuanterix Corporation
29/04/202422h00Business WireQuanterix To Report First Quarter 2024 Financial ResultsNASDAQ:QTRXQuanterix Corporation
21/03/202422h30Business WireQuanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing InfrastructureNASDAQ:QTRXQuanterix Corporation
04/03/202423h27Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:QTRXQuanterix Corporation
04/03/202415h00Business WireQuanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer’s DiseaseNASDAQ:QTRXQuanterix Corporation
29/02/202422h58Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:QTRXQuanterix Corporation
29/02/202422h00Business WireQuanterix Releases Operating Results for Fourth Quarter and Full Year 2023NASDAQ:QTRXQuanterix Corporation
27/02/202400h58Business WireQuanterix Reschedules Q4 and Full Year 2023 Earnings Conference Call; Reaffirms 2023 GuidanceNASDAQ:QTRXQuanterix Corporation
26/02/202415h00Business WireQuanterix Announces First Collaborations with Five Health Networks to Aid the Diagnosis and Clinical Management of Individuals with Alzheimer’s DiseaseNASDAQ:QTRXQuanterix Corporation
23/02/202422h30Business WireQuanterix to Present at Cowen’s 44th Annual Health Care ConferenceNASDAQ:QTRXQuanterix Corporation
16/02/202422h00Business WireQuanterix Fourth Quarter Earnings and Full Year 2023 Financial Results Conference CallNASDAQ:QTRXQuanterix Corporation
14/02/202422h57Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:QTRXQuanterix Corporation
12/12/202322h00Business WireQuanterix to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:QTRXQuanterix Corporation
13/11/202322h00Business WireQuanterix To Participate at The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNASDAQ:QTRXQuanterix Corporation
 Showing the most relevant articles for your search:NASDAQ:QTRX

Dernières Valeurs Consultées

NASDAQ
HTLF
Heartland Financial USA
COIN
IFXGBP
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés